Ingrid Dahlin Named to 2022 PM360 ELITE 100
KANSAS CITY, MO— MAY 17, 2022 – CrowdPharm, a full-service agency with the largest network of global talent in healthcare, announces today that PM360, the premier information resource for marketing decision-makers in the pharmaceutical, biotech, diagnostics, and medical device sectors, has named CrowdPharm’s Ingrid Dahlin as one of the 2022 PM360 ELITE 100 in the Mentors category. In its eighth year, the PM360 ELITE (Exceptional. Leaders. Innovators. Transformers. Entrepreneurs) represent the most influential people in the healthcare industry today.
“Ingrid has been mentoring and guiding the engagement of the company’s talented members to achieve the best possible results for our team and clients since day one,” said Mike Myers, Managing Director and Partner. “She leads us forward and transforms the way we work every day.”
CrowdPharm is a full-service agency offering something no one else in healthcare marketing has provided to clients and brands before—a full-time team directly connected with 4,700+ global specialists across 100+ countries. The agency’s unique approach provides the consistency and dedication brands require, turbocharged with access to one of the largest global healthcare talent pools ever created. Through hard work and proprietary technology, CrowdPharm’s full-time industry veterans created a network of vetted on-demand healthcare talent that allows them to customize teams scaled to client needs, keep work moving around the globe, and provide flexible and cost-effective solutions. Different by design, CrowdPharm delivers compelling brand communications in healthcare, medical, and pharmaceutical marketing.
“I am humbled by this nomination,” said Ingrid Dahlin, Managing Director, Account Services. “The professional development and success of my colleagues has always been important to me, and I always do what I can to provide support and guidance.”
The PM360 ELITE Awards were established in 2015 to recognize individuals and teams who have made a significant impact on the life sciences and healthcare industries throughout their careers. More than 500 submissions were received, and nominees were evaluated and selected by the PM360 editorial staff based on their accomplishments; testimonials from their bosses, clients, and colleagues; and supporting evidence that reflects the impact of their efforts. A total of 100 winners were selected across 20 categories, including Creative Directors, Data Miners, Digital Crusaders, Disrupters, Drug Researchers and Developers, Entrepreneurs, Environmental Champions, Launch Experts, Leaders of the Future, Marketing Teams, Master Educators, Mentors, Patient Advocates, Philanthropic Heroes, PR Gurus, Sales MVPs, Strategists, Talent Acquisition Leaders, Tech-know Geeks, and Transformational Leaders.
“Our industry accomplished great things during the pandemic to ensure people could be protected against COVID, treated for it, and still access all the other medications they need, but this disruption to our world also revealed ways in which our industry could be even better,” says Anna Stashower, CEO and Publisher of PM360. “Many of this year’s winners sprang into action to improve areas the pandemic exposed as needing changes, including addressing health equity, social determinants of health, clinical research, patient access and affordability, and much more. That’s what makes them the most influential people our industry has to offer—their ability to push the industry forward to make healthcare better for all.”
CrowdPharm is a full-service agency led by industry veterans and fueled by the largest network of global healthcare talent anywhere. Innovative technology enables the agency to deliver an abundance of original strategic and creative solutions and provide a flexible force of talent with experience that spans startups, orphan products, blockbusters, and primary care. With 4,700+ members across 100+ countries, the agency is ready to develop compelling brand communications in healthcare, medical, and pharmaceutical marketing for pharmaceutical and biopharma companies. Visit crowdpharm.com.
PM360 is the premier, must-read magazine for marketing decision-makers in the pharmaceutical, biotech, diagnostics, and medical device industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharmaceutical marketing professionals to succeed in the complex and highly regulated healthcare environment. The journal’s targeted and insightful editorial focuses on issues that directly impact critical decision-making, including planning and implementing cutting-edge strategies, trends, the latest technological advances, branding/marketing, advertising/promotion, patient/professional education, sales, market research, PR, and leadership. Additionally, the “360” in the title signifies the span of this critical, how-to info with personal and career insights for an enjoyable and thought-provoking read. By providing the full circle of enriching content, PM360 is truly an indispensable tool for busy and productive marketing professionals to stay at the top of their game.
For more information, contact:
VP, Director of Marketing and Corporate Communications